Z-1954-2021 Class I Terminated
FDA device recall Z-1954-2021 was initiated by Magellan Diagnostics, Inc. on May 7, 2021 and is designated Class I. Reason for recall: Magellan has received reports that control tests of either the Low-Control and/or the High-Control generated a low result. The issue may cause the underestimation of blood lead levels in patient… The recall status is terminated (terminated Oct 24, 2023). Affected quantity: 441 kits (192 tests/kit = 84,672 tests).
Recall details
- Product Type
- Devices
- Report Date
- Jul 7, 2021
- Initiation Date
- May 7, 2021
- Termination Date
- Oct 24, 2023
- Voluntary/Mandated
- Voluntary: Firm initiated
- Product Quantity
- 441 kits (192 tests/kit = 84,672 tests)
Product description
LeadCare Ultra Blood Lead Test Kit Catalog Number 70-8098
Reason for recall
Magellan has received reports that control tests of either the Low-Control and/or the High-Control generated a low result. The issue may cause the underestimation of blood lead levels in patient samples.
Distribution pattern
Worldwide distribution. US nationwide including Puerto Rico; Canada, Vietnam, India, Italy, Peru, New Zealand, Australia, Hong Kong, and Philippines.
Code information
Lot Numbers/Expiration Date: 2011MU - 25MAR22. 1st expansion 6/21/2021: 2104MU - 25AUG22; 2108MU - 31MAR22.
Source
- Dataset
- openFDA device recall enforcement reports
- FDA record
- This recall in openFDA (JSON)
- Enforcement Report
- Search FDA's Enforcement Report for Z-1954-2021
- openFDA file date
- Nov 10, 2026
- Loaded by RegDataLab
- Nov 11, 2026